Quick Summary
This study investigated whether Long COVID patients with fatigue and mood symptoms have immune system problems affecting their gut barrier and nerve tissue. Researchers tested blood samples from 90 Long COVID patients and 90 healthy people, measuring antibodies and inflammatory markers. They found that specific immune responses to gut barrier proteins and bacterial toxins were linked to Long COVID diagnosis and symptom severity.
Why It Matters
This study proposes a mechanistic pathway linking viral reactivation, gut barrier dysfunction, and neuroinflammation in Long COVID—potentially applicable to ME/CFS. If tight junction breakdown and bacterial translocation drive symptoms, this could inform new diagnostic biomarkers and therapeutic targets for post-viral fatigue syndromes. Understanding these immune mechanisms may help distinguish Long COVID/ME/CFS from other conditions.
Observed Findings
What the study reports it measured.
- IgA-LPS, IgG-ZOOC, IgG-LPS, and IgA-ZOOC antibodies were identified as predictive markers for Long COVID diagnosis (ROC AUC 0.755).
- CRP, IgA-MBP, and IgG-MBP accounted for 40.9% of variance in combined physical and affective symptoms.
- Tight junction autoimmunity (IgA and IgG to ZOOC) explained 36.3–39.7% of variance in autoimmunity to myelin basic protein.
- HHV-6 reactivation indicators were strongly associated with anti-ZOOC autoimmunity and elevated IgM-SARS-CoV-2.
Inferred Conclusions
What the authors interpret from those results.
- Autoimmunity against tight junction proteins and increased bacterial translocation may be central pathophysiological features of Long COVID's combined physical-affective symptoms.
- HHV-6 reactivation may trigger or amplify autoimmune responses to the intestinal barrier and neuronal antigens.
- The tight junction-HHV-6-neuroinflammation axis may represent a unified pathogenic mechanism linking viral persistence, gut permeability, and systemic inflammation in Long COVID.
Remaining Questions
- Is the observed autoimmunity primary (driving pathology) or secondary (resulting from tissue damage)?
- Do anti-tight junction antibodies directly impair barrier function, or are they epiphenomena of ongoing viral reactivation?
- Can targeting HHV-6 reactivation, gut barrier dysfunction, or autoimmunity reduce Long COVID symptoms in intervention studies?
- How do these findings relate to ME/CFS in the pre-pandemic population, and are the mechanisms identical?
What This Study Does Not Prove
This study does not prove causation; it only shows associations in a single time-point snapshot. It does not establish whether tight junction autoimmunity causes symptom development or results from it. The findings cannot be generalized beyond the studied Long COVID population without replication, and do not rule out alternative explanatory pathways.
Explore further
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Cite this study
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Maes, Michael, Almulla, Abbas F, Tang, Xiaoou, Stoyanova, Kristina, & Vojdani, Aristo (2024). From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.. Journal of medical virology. https://doi.org/10.1002/jmv.29864
BibTeX
@article{mecfsatlas-maes-2024-human-herpes,
author = {Maes, Michael and Almulla, Abbas F and Tang, Xiaoou and Stoyanova, Kristina and Vojdani, Aristo},
title = {From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.},
journal = {Journal of medical virology},
year = {2024},
doi = {10.1002/jmv.29864},
note = {PubMed: 39158051},
url = {https://www.mecfsatlas.com/evidence/maes-2024-human-herpes},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-13. https://www.mecfsatlas.com/evidence/maes-2024-human-herpes
Contribute
Private, reviewed by a human. Not a public comment thread.